3rd Quarter - Report

GOVERNMENT SOLUTIONS LLC for GINKGO BIOWORKS

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Engineered and synthetic biology related policy issues, specifically relating to research and development, biosecurity, and bioresources. Also, bioengineering related regulatory standards and international trade issues.

LobbyistCovered position, as disclosed
BERT STEELE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Engineered and synthetic biology related policy issues, specifically relating to research and development, biosecurity, and bioresources. Also, bioengineering related regulatory standards and international trade issues. H.R. 4373, The Engineering Biology Research and Development Act of 2019.

LobbyistCovered position, as disclosed
BERT STEELE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4373 (116th)

Natural Resources NAT

Engineered and synthetic biology related policy issues, specifically relating to research and development, biosecurity, and bioresources. Also, bioengineering related regulatory standards and international trade issues.

LobbyistCovered position, as disclosed
BERT STEELE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Engineered and synthetic biology related policy issues, specifically relating to research and development, biosecurity, and bioresources. Also, bioengineering related regulatory standards and international trade issues.

LobbyistCovered position, as disclosed
BERT STEELE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.